Data Sheet 1_Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease.pdf

Introduction<p>Patients with advanced chronic disease (ACD) experience transitions in their clinical stability, leading to increased healthcare resource use and costs. EU-funded ADLIFE digital intervention aimed to ensure their quality of life through individualised care plans, clinical decisi...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autor principal:	Igor Larrañaga (5434382) (author)
Altres autors:	Javier Mar (85334) (author), Ania Gorostiza (8833430) (author), Borja García-Lorenzo (10196950) (author), Beñat Zubeltzu (22687214) (author), Remedios Vega (22687217) (author), Rachelle Kaye (6829220) (author), Gil Levy (4002569) (author), Olga Vishnevetsky (22687220) (author), Rikke Lyngholm Christensen (22687223) (author), Anne Dichmann Sorknæs (18935599) (author), Natassia Garton (22687226) (author), Anne Swoboda (22687229) (author), Fritz Arndt (17711075) (author), Lisa McCann (6167027) (author), Roma Maguire (6167015) (author), Morven Miller (22687232) (author), Gokce B. Laleci Erturkmen (18617965) (author), Mustafa Yuksel (4269145) (author), Theodoros N. Arvanitis (2178638) (author), Chao Tong (389167) (author), Jose I. Aznar-Baranda (22687235) (author), Jessica Caballero (22687238) (author), Nerea González (5464928) (author), Juan de la Torre (22687241) (author), Dolores Verdoy (9085276) (author), Esteban de Manuel Keenoy (9085279) (author), Ane Fullaondo (452170) (author), ADLIFE Consortium (22687244) (author)
Publicat:	2025
Matèries:	Public Health and Health Services not elsewhere classified advanced chronic disease digital health integrated care personalised care plan simulation model discrete event simulation economic evaluation budget impact analysis
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!

Data Sheet 1_Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease.pdf

Ítems similars